AYTU
NASDAQ · Pharmaceuticals
Aytu Biopharma Inc
$2.32
-0.01 (-0.43%)
Open$2.32
Previous Close$2.33
Day High$2.36
Day Low$2.30
52W High$3.07
52W Low$1.65
Volume—
Avg Volume33.1K
Market Cap24.85M
P/E Ratio—
EPS$-4.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+294.4% upside
Current
$2.32
$2.32
Target
$9.15
$9.15
$5.34
$9.15 avg
$10.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 113.21M | 128.35M | 4.25M |
| Net Income | -23,129,477 | -23,598,831 | 1.24M |
| Profit Margin | -20.4% | -19.4% | 29.2% |
| EBITDA | -7,067,578 | -7,611,607 | 1.93M |
| Free Cash Flow | — | — | 869.5K |
| Rev Growth | -11.8% | -11.8% | +20.1% |
| Debt/Equity | 1.15 | 1.15 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |